Terms: = Gastric cancer AND HRAS, K-ras, 3265, ENSG00000174775, HRAS1, RASH1, c-bas/has, P01112, N-ras AND Prognosis
18 results:
1. Machine learning models predict the mTOR signal pathway-related signature in the gastric cancer involving 2063 samples of 7 centers.
Zhang H; Zhuo H; Hou J; Cai J
Aging (Albany NY); 2023 Jun; 15(13):6152-6162. PubMed ID: 37341987
[TBL] [Abstract] [Full Text] [Related]
2. Bcl-2 and Noxa are potential prognostic indicators for patients with gastroenteropancreatic neuroendocrine neoplasms.
Guo Y; Zhang L; Zhang N; Chen L; Luo Q; Liu M; Yang D; Chen J
Endocrine; 2022 Oct; 78(1):159-168. PubMed ID: 35895181
[TBL] [Abstract] [Full Text] [Related]
3. [Clinical analysis of 12 cases of acute myeloid leukemia complicated with synchronous primary solid tumor].
Mi RH; Dang HB; Chen L; Han YL; Wang MF; Zhang YL; Chen L; Li DB; Wei XD
Zhonghua Yi Xue Za Zhi; 2020 Nov; 100(42):3323-3327. PubMed ID: 33202495
[No Abstract] [Full Text] [Related]
4. GNAS but Not Extended RAS Mutations Spectrum are Associated with a Better prognosis in Intraductal Pancreatic Mucinous Neoplasms.
Gaujoux S; Parvanescu A; Cesaretti M; Silve C; Bieche I; Rebours V; Lévy P; Sauvanet A; Cros J
Ann Surg Oncol; 2019 Aug; 26(8):2640-2650. PubMed ID: 31025231
[TBL] [Abstract] [Full Text] [Related]
5. Dietary Garcinol Arrests Pancreatic cancer in p53 and k-ras Conditional Mutant Mouse Model.
Saadat N; Akhtar S; Goja A; Razalli NH; Geamanu A; David D; Shen Y; Gupta SV
Nutr Cancer; 2018 Oct; 70(7):1075-1087. PubMed ID: 30273070
[TBL] [Abstract] [Full Text] [Related]
6. Correlations of IGF-1R and COX-2 Expressions with Ras and BRAF Genetic Mutations, Clinicopathological Features and prognosis of Colorectal cancer Patients.
Jin M; Long ZW; Yang J; Lin X
Pathol Oncol Res; 2018 Jan; 24(1):45-57. PubMed ID: 28188432
[TBL] [Abstract] [Full Text] [Related]
7. [Research advances of k-ras mutation in the prognosis and targeted therapy of gastric cancer].
Huang Y; Wei J; Liu BR
Zhonghua Zhong Liu Za Zhi; 2016 Feb; 38(2):81-5. PubMed ID: 26899324
[TBL] [Abstract] [Full Text] [Related]
8. The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines.
Nishida T; Blay JY; Hirota S; Kitagawa Y; Kang YK
Gastric Cancer; 2016 Jan; 19(1):3-14. PubMed ID: 26276366
[TBL] [Abstract] [Full Text] [Related]
9. Correlation of COX-2 and k-ras expression to clinical outcome in gastric cancer.
Li M; Liu W; Zhu YF; Chen YL; Zhang BZ; Wang R
Acta Oncol; 2006; 45(8):1115-9. PubMed ID: 17118848
[TBL] [Abstract] [Full Text] [Related]
10. Genetic, epigenetic, and clinicopathologic features of gastric carcinomas with the CpG island methylator phenotype and an association with Epstein-Barr virus.
Kusano M; Toyota M; Suzuki H; Akino K; Aoki F; Fujita M; Hosokawa M; Shinomura Y; Imai K; Tokino T
Cancer; 2006 Apr; 106(7):1467-79. PubMed ID: 16518809
[TBL] [Abstract] [Full Text] [Related]
11. H-ras mutation is an additional event of sarcomatous transformation in aerodigestive spindle cell carcinoma.
Shiratsuchi H; Hirakawa N; Saito T; Oda Y; Yamamoto H; Tomita K; Yamamoto T; Tsuneyoshi M
Oncol Rep; 2004 Mar; 11(3):597-604. PubMed ID: 14767509
[TBL] [Abstract] [Full Text] [Related]
12. Epigenetic inactivation of the Ras-association domain family 1 (RASSF1A) gene and its function in human carcinogenesis.
Dammann R; Schagdarsurengin U; Strunnikova M; Rastetter M; Seidel C; Liu L; Tommasi S; Pfeifer GP
Histol Histopathol; 2003 Apr; 18(2):665-77. PubMed ID: 12647816
[TBL] [Abstract] [Full Text] [Related]
13. Role of tumour markers, cytogenetics.
Lamerz R
Ann Oncol; 1999; 10 Suppl 4():145-9. PubMed ID: 10436809
[TBL] [Abstract] [Full Text] [Related]
14. prognosis of human pancreatic adenocarcinoma: review of clinical and histopathological variables and possible uses of new molecular methods.
Eskelinen MJ; Haglund UH
Eur J Surg; 1999 Apr; 165(4):292-306. PubMed ID: 10365829
[TBL] [Abstract] [Full Text] [Related]
15. Gene amplification and proliferative kinetics in relation to prognosis of patients with gastric carcinoma.
Amadori D; Maltoni M; Volpi A; Nanni O; Scarpi E; Renault B; Pellegata NS; Gaudio M; Magni E; Ranzani GN
Cancer; 1997 Jan; 79(2):226-32. PubMed ID: 9010095
[TBL] [Abstract] [Full Text] [Related]
16. Expression of Kirsten-ras p21 in gastric cancer correlates with tumor progression and is prognostic.
Motojima K; Furui J; Kohara N; Izawa K; Kanematsu T; Shiku H
Diagn Mol Pathol; 1994 Sep; 3(3):184-91. PubMed ID: 7981894
[TBL] [Abstract] [Full Text] [Related]
17. The use of serologic tumor markers in gastrointestinal malignancies.
Posner MR; Mayer RJ
Hematol Oncol Clin North Am; 1994 Jun; 8(3):533-53. PubMed ID: 8707771
[TBL] [Abstract] [Full Text] [Related]
18. Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and k-ras, p53 and c-erbB-2 abnormalities in 26 patients.
Sessa F; Solcia E; Capella C; Bonato M; Scarpa A; Zamboni G; Pellegata NS; Ranzani GN; Rickaert F; Klöppel G
Virchows Arch; 1994; 425(4):357-67. PubMed ID: 7820300
[TBL] [Abstract] [Full Text] [Related]
